Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Cg Oncology Inc’s stock clocked out at $25.43, up 0.32% from its previous closing price of $25.35. In other words, the price has increased by $0.32 from its previous closing price. On the day, 1.23 million shares were traded.
Ratios:
To gain a deeper understanding of CGON’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 30.97 and its Current Ratio is at 30.97. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on May 02, 2025, initiated with a Overweight rating and assigned the stock a target price of $41.
On April 16, 2025, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $23.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 28 ’25 when POST LEONARD E sold 1,000 shares for $30.76 per share. The transaction valued at 30,760 led to the insider holds 0 shares of the business.
POST LEONARD E sold 1,000 shares of CGON for $28,000 on Mar 17 ’25. The Director now owns 0 shares after completing the transaction at $28.00 per share. On Mar 17 ’25, another insider, LEONARD E POST, who serves as the Director of the company, bought 4,000 shares for $27.80 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2936.98 while its Price-to-Book (P/B) ratio in mrq is 2.75.
Stock Price History:
Over the past 52 weeks, CGON has reached a high of $40.47, while it has fallen to a 52-week low of $14.80. The 50-Day Moving Average of the stock is 6.40%, while the 200-Day Moving Average is calculated to be -17.31%.
Shares Statistics:
A total of 76.22M shares are outstanding, with a floating share count of 44.88M. Insiders hold about 39.61% of the company’s shares, while institutions hold 71.47% stake in the company.